Associated Papers
Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative Review.
Micolonghi C et al.
International Journal of Molecular Sciences, 2024
Dilated cardiomyopathy mutations in δ-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability.
Campbell MD et al.
American Journal of Physiology. Heart and Circulatory Physiology, 2016
Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity.
Garcia J et al.
Frontiers in Cardiovascular Medicine, 2016
27446933 (PubMed )
Supplement: data_sheet_1.docx
A Haplotype of Two Novel Polymorphisms in δ-Sarcoglycan Gene Increases Risk of Dilated Cardiomyopathy in Mongoloid Population.
Chen J et al.
Plos One, 2015
δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.
Blain AM et al.
Skeletal Muscle, 2011
Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.
Callis TE et al.
Expert Review of Molecular Diagnostics, 2010
Delta-sarcoglycan gene polymorphism frequency in Amerindian and Mestizo populations of Mexico.
Ordoñez-Razo RM et al.
Genetic Testing and Molecular Biomarkers, 2010
The canine sarcoglycan delta gene: BAC clone contig assembly, chromosome assignment and interrogation as a candidate gene for dilated cardiomyopathy in Dobermann dogs.
Stabej P et al.
Cytogenetic and Genome Research, 2005
A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy.
Kärkkäinen S et al.
Journal of Molecular Medicine (berlin, Germany), 2003
Select a paper to view details